Display Settings:

Format

Send to:

Choose Destination
Accession: PRJEB20969 ID: 429602

Targeted next generation sequencing of cfDNA from lung cancer patients enrolled in the GALAXY-1 trial (NCT01348126)

We evaluated whether targeted next-generation sequencing (NGS) using the Ion Torrent Personal Genome Sequencer of cfDNA could identify prognostic or predictive factors for overall survival (OS) or progression free survival (PFS) within a large cohort of patients with advanced lung adenocarcinoma enrolled in the GALAXY-1 trial.
AccessionPRJEB20969
ScopeMonoisolate
SubmissionRegistration date: 11-Jan-2018
MRC Toxicology Unit
Project Data:
Resource NameNumber
of Links
Sequence data
SRA Experiments306
Other datasets
BioSample306
SRA Data Details
ParameterValue
Data volume, Gbases7
Data volume, Mbytes10217

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center